Updated on 2024/03/30

写真a

 
SUMIYOSHI,Takaaki
 
Organization
Faculty of Chemistry, Materials and Bioengineering Professor
Title
Professor
Contact information
メールアドレス
External link

Degree

  • Ph.D. ( 2005.3 )

Research Areas

  • Nanotechnology/Materials / Synthetic organic chemistry

  • Life Science / Neuroscience-general

  • Life Science / Pharmaceutical chemistry and drug development sciences

  • Life Science / Biomedical engineering

Education

  • Kyoto University   Graduate School, Division of Pharmaceutical Sciences

    - 2005

      More details

  • Kyoto University   Faculty of Pharmaceutical Science

    - 1999

      More details

    Country: Japan

    researchmap

  • Kyoto University   Graduate School, Division of Pharmaceutical Sciences

    2001

      More details

    Country: Japan

    researchmap

  • Kyoto University   Graduate School, Division of Pharmaceutical Sciences

    2005

      More details

    Country: Japan

    researchmap

Research History

  • 大日本住友製薬株式会社 先端創薬研究所 主任研究員

    2013.4 - 2014.3

      More details

  • 大日本住友製薬株式会社 化学研究所 主任研究員

    2010.7 - 2013.3

      More details

  • 大日本住友製薬株式会社 化学研究所

    2005.10 - 2010.6

      More details

  • 大日本製薬株式会社 化学研究所

    2005.4 - 2005.9

      More details

Professional Memberships

Committee Memberships

  •   近畿支部 副支部長  

    2015.4 - 2017.3   

      More details

  •   Editor  

    2013.4 - 2016.3   

      More details

  •   Editor  

    2013.4 - 2016.3   

      More details

Papers

  • MDMX elevation by a novel Mdmx-p53 interaction inhibitor mitigates neuronal damage after ischemic stroke. International journal

    Haomin Yan, Tsutomu Sasaki, Hideaki Kanki, Yoshiyuki Hirata, Kumiko Nishiyama, Sunao Hisada, Shigenobu Matsumura, Yasuo Nagaoka, Takaaki Sumiyoshi, Seiichi Nagano, Akiko Nakata, Minoru Yoshida, Shinichi Uesato, Hideki Mochizuki

    Scientific reports   12 ( 1 )   21110 - 21110   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mdmx and Mdm2 are two major suppressor factors for the tumor suppressor gene p53. In central nervous system, Mdmx suppresses the transcriptional activity of p53 and enhances the binding of Mdm2 to p53 for degradation. But Mdmx dynamics in cerebral infarction remained obscure. Here we investigated the role of Mdmx under ischemic conditions and evaluated the effects of our developed small-molecule Protein-Protein Interaction (PPI) inhibitors, K-181, on Mdmx-p53 interactions in vivo and in vitro. We found ischemic stroke decreased Mdmx expression with increased phosphorylation of Mdmx Serine 367, while Mdmx overexpression by AAV-Mdmx showed a neuroprotective effect on neurons. The PPI inhibitor, K-181 attenuated the neurological deficits by increasing Mdmx expression in post-stroke mice brain. Additionally, K-181 selectively inhibited HDAC6 activity and enhanced tubulin acetylation. Our findings clarified the dynamics of Mdmx in cerebral ischemia and provide a clue for the future pharmaceutic development of ischemic stroke.

    DOI: 10.1038/s41598-022-25427-4

    PubMed

    researchmap

  • Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier Reviewed

    Toshiki Kurosawa, Yuma Tega, Yasuo Uchida, Kei Higuchi, Hidetsugu Tabata, Takaaki Sumiyoshi, Yoshiyuki Kubo, Tetsuya Terasaki, Yoshiharu Deguchi

    Pharmaceutics   14(8), 1683 ( 8 )   1683 - 1683   2022.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    A proton-coupled organic cation (H+/OC) antiporter working at the blood–brain barrier (BBB) in humans and rodents is thought to be a promising candidate for the efficient delivery of cationic drugs to the brain. Therefore, it is important to identify the molecular entity that exhibits this activity. Here, for this purpose, we established the Proteomics-based Identification of transporter by Crosslinking substrate in Keyhole (PICK) method, which combines photo-affinity labeling with comprehensive proteomics analysis using SWATH-MS. Using preselected criteria, the PICK method generated sixteen candidate proteins. From these, knockdown screening in hCMEC/D3 cells, an in vitro BBB model, identified two proteins, TM7SF3 and LHFPL6, as candidates for the H+/OC antiporter. We synthesized a novel H+/OC antiporter substrate for functional analysis of TM7SF3 and LHFPL6 in hCMEC/D3 cells and HEK293 cells. The results suggested that both TM7SF3 and LHFPL6 are components of the H+/OC antiporter.

    DOI: 10.3390/pharmaceutics14081683

    researchmap

  • Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 Inhibitors

    Kosuke Hashimoto, Soichiro Ide, Mayumi Arata, Akiko Nakata, Akihiro Ito, Takashi K. Ito, Norio Kudo, Bangzhong Lin, Kazuto Nunomura, Keiko Tsuganezawa, Minoru Yoshida, Yasuo Nagaoka, Takaaki Sumiyoshi

    ACS Medicinal Chemistry Letters   2022.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acsmedchemlett.2c00081

    researchmap

  • GPR91 antagonist and TGF-β inhibitor suppressed collagen production of high glucose and succinate induced HSC activation Reviewed

    Sakai, Mutsuko, Sumiyoshi, Takaaki, Aoyama, Takuya, Urayama, Kenji, Yoshimura, Ryoichi

    Biochem. Biophys. Res. Commun.   2020, 530, 362–366.   2020.8

     More details

  • A novel piperidine degradation mechanism in a newly isolated piperidine degrader <i>Pseudomonas</i> sp. strain KU43P Reviewed

    Taisei Yamamoto, Yaxuan Liu, Takaaki Sumiyoshi, Yoshie Hasegawa, Hiroaki Iwaki

    The Journal of General and Applied Microbiology   2020, 66, 265-272. ( 5 )   265 - 272   2020.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Microbiology Research Foundation  

    DOI: 10.2323/jgam.2019.11.006

    researchmap

  • Identification and Quantification of Short-Chain Aldehydes Generated from Hair by Ultraviolet Ray Irradiation Reviewed

    Horibe, Ippei, Kitayama, Shintaro, Nagai, Mizuki, Kokuwano, Yuri, Nakai, Ayaka, SUMIYOSHI, Takaaki, NAGAOKA, Yasuo

    J. Soc. Cosmet. Chem. Jpn.   2020, 54, 169–176.   2020.6

     More details

  • Design, Synthesis and Structure-Activity Relationship Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors Reviewed

    Seiya Hiranaka, Mayumi Arata, Akiko Nakata, Akiko Tanaka, Yoshinobu Hashizume, Norio Kudo, Akihiro Ito, Minoru Yoshida, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    Design, Synthesis and Structure-Activity Relationship Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors   101 ( 2 )   726 - 737   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Nano-Honeycomb Electrode-based QCM Sensor and Its Application for PPI Detection Reviewed

    Naoto Asai, Naohiro Matsumoto, Nozomi Kazama, Yasuo Nagaoka, Takaaki Sumiyoshi, Tomohiro Shimizu, Shoso Shingubara, Takeshi Ito

    IEEE Sensors Journal   2019, 19, 4025-4030.   2019.2

     More details

  • Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds Reviewed

    夏谷 格, 岩田吏世, 山井悠介, 石田恭次, 長岡康夫, 住吉孝明

    Chemical Biology & Drug Design   2019, 93, 657-665.   2019.2

     More details

    Drug design using boron‐containing heterocycles has attracted a great deal of attention because these compounds are believed to possess high biological activity. However, information on the synthetic methodology and pharmacokinetic profiling of boron‐containing compounds is limited. In this study, we provide a new synthetic route for preparation of spiro‐fused benzoxaborin derivatives and investigate their in vitro pharmacokinetic properties. Our efforts led to the successful construction of a chemical library of spiro‐fused benzoxaborin derivatives with appropriate physicochemical and in vitro pharmacokinetic properties for oral drugs. These results indicate that the synthesized boron‐containing compounds are therefore eligible for classification in a novel chemical library.

    DOI: 10.1111/cbdd.13496

    researchmap

  • Asymmetric Synthesis of t-Butyl 3-Alkyl-oxindole-3-carboxylates via Chiral Phosphoric Acid-Catalyzed Desymmetrization of Di-t-butyl 2-Alkyl-2-(2-aminophenyl)malonates

    Kyoji Ishida, Masahiro Shimizu, Yusuke Yamai, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    Heterocycles   99(2), 1398 -1411   2019.2

  • SYNTHESIS OF SUBSTITUTED t-BUTYL 3-ALKYLOXINDOLE-3-CARBOXYLATES FROM DI-t-BUTYL (2-NITROPHENYL)MALONATES

    Yu-suke Yamai, Akio Tanaka, Tatsuo Yajima, Kyoji Ishida, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    HETEROCYCLES   97 ( 1 )   192 - 210   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Using a novel tandem reduction-cyclization, we synthesized t-butyl 3-alkyloxindole-3-carboxylates from the di-t-butyl 2-alkyl-2-(2-nitrophenyl)malonate. Introduction of an alpha-substituent to the di-t-butyl 2-(2-nitrophenyl)-malonates and addition of acid promoted reactivity. This methodology was successfully applied to gram-scale-synthesis of the t-butyl 3-methyloxindole-3-carboxylate 1 and 3-hydroxyrnethy1-3-methyloxindole 2 without silica gel column chromatography.

    DOI: 10.3987/COM-17-S(T)2

    Web of Science

    researchmap

  • Design, Synthesis, and Blood-Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors. Reviewed International journal

    Seiya Hiranaka, Yuma Tega, Kei Higuchi, Toshiki Kurosawa, Yoshiharu Deguchi, Mayumi Arata, Akihiro Ito, Minoru Yoshida, Yasuo Nagaoka, Takaaki Sumiyoshi

    ACS medicinal chemistry letters   2018, 9, 884–888. ( 9 )   884 - 888   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We designed and synthesized a pyrilamine derivative 1 as a selective class I HDAC inhibitor that targets pyrilamine-sensitive proton-coupled organic cation antiporter (PYSOCA) at the blood-brain barrier (BBB). Introduction of pyrilamine moiety to benzamide type HDAC inhibitors kept selective class I HDAC inhibitory activity and increased BBB permeability. Our BBB transport study showed that compound 1 is a substrate of PYSOCA. Thus, our findings suggest that the hybrid method of HDAC inhibitor and substrate of PYSOCA such as pyrilamine is useful for development of HDAC inhibitors with increased BBB permeability.

    DOI: 10.1021/acsmedchemlett.8b00099

    PubMed

    researchmap

  • Efficient Synthesis of t-Butyl 3-Alkyl-N-hydroxyoxindole-3-carboxylates from Di-t-butyl 2-nitrophenylmalonates Reviewed

    Yu-suke Yamai, Kyoji Ishida, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Suiyoshi

    Heterocycles   2018, 97, 1257–1268.   2018.5

  • Synthesis of Substituted t-Butyl 3-Alkyl-oxindole-3-carboxylates from Di-t-Butyl (2-Nitrophenyl)malonates Reviewed

    YAMAI, Yu-suke, TANAKA, Akio, YAJIMA, Tatsuo, ISHIDA. Kyoji, NATSUTANI, Itaru, UESATO, Shinichi, NAGAOKA, Yasuo, SUMIYOSHI, Takaaki

    Heterocycles   2018, 97, 192–210.   2017.12

     More details

  • Process Development for the Synthesis of a Selective M-1 and M-4 Muscarinic Acetylcholine Receptors Agonist

    Yoshiharu Uruno, Kazuki Hashimoto, Yoichi Hiyama, Takaaki Sumiyoshi

    ORGANIC PROCESS RESEARCH & DEVELOPMENT   21 ( 10 )   1610 - 1615   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A practical and chromatography-free synthetic process to selective M-1 and M-4 muscarinic acetylcholine receptors agonist was developed and demonstrated on a several hundred gram scale. The key feature of this route is N,N- dimethylcarbamoylation of the anilinic nitrogen on the spiro 7-azaindoline structure via intermolecular migration of the NjN- dimethylcarbamoyl group. The resulting compound 1 was prepared in 43% overall yield with a chemical purity &gt;99% via six steps starting with (2-chloropyridin-3-yl)acetonitrile.

    DOI: 10.1021/acs.oprd.7b00236

    Web of Science

    researchmap

  • Discovery of new low-molecular-weight p53-Mdmx disruptors and their anti-cancer activities

    Shinichi Uesato, Yoshihiro Matsuura, Saki Matsue, Takaaki Sumiyoshi, Yoshiyuki Hirata, Suzuho Takemoto, Yasuyuki Kawaratani, Yusuke Yamai, Kyoji Ishida, Tsutomu Sasaki, Masato Enari

    BIOORGANIC & MEDICINAL CHEMISTRY   24 ( 8 )   1919 - 1926   2016.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Although several p53-Mdm2-binding disruptors have been identified to date, few studies have been published on p53-Mdmx-interaction inhibitors. In the present study, we demonstrated that o-aminothiophenol derivatives with molecular weights of 200-300 selectively inhibited the p53-Mdmx interaction. S-2-Isobutyramidophenyl 2-methylpropanethioate (K-178) (1c) activated p53, up-regulated the expression of its downstream genes such as p21 and Mdm2, and preferentially inhibited the growth of cancer cells with wild-type p53 over those with mutant p53. Furthermore, we found that the S-isobutyryl-deprotected forms 1b and 3b of 1c and S-2-benzamidophenyl 2-methylpropanethioate (K-181) (3c) preferentially inhibited the p53-Mdmx interaction over the p53-Mdm2 interaction, respectively, by using a Flag-p53 and glutathione S-transferase (GST)-fused protein complex (Mdm2, Mdmx, DAPK1, or PPID). In addition, the interaction of p53 with Mdmx was lost by replacing a sulfur atom with an oxygen atom in 1b and 1c. These results suggest that sulfides such as 1b, 3b, 4b, and 5b interfere with the binding of p53-Mdmx, resulting in the dissociation of the two proteins. Furthermore, the results of oral administration experiments using xenografts in nude mice indicated that 1c reduced the volume of tumor masses to 49.0% and 36.6% that of the control at 100 mg/kg and 150 mg/kg, respectively, in 40 days. (C) 2016 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2016.03.021

    Web of Science

    researchmap

  • Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M-1 and M-4 muscarinic acetylcholine receptors agonists

    Yoshiharu Uruno, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Kengo Tojo, Tomokazu Nakako, Mutsuko Sakai, Takeshi Enomoto, Harumi Matsuda, Atsushi Kitamura, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   25 ( 22 )   5357 - 5361   2015.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized a series of dihydroquinazolinone derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors agonists. Introduction of the N-carbethoxy piperidine unit into a HTS hit compound followed by optimization of the amine linker and the carbamoyl moiety led to the identification of compound 1 as a potential candidate. The identified compound 1 showed high selectivity for M-1 and M-4 muscarinic acetylcholine receptors with M-4 partial agonistic activity. In addition, compound 1 showed good brain penetration and reversed methamphetamine-induced hyperlocomotion in rats (ED50 = 3.0 mg/kg, sc). (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2015.09.032

    Web of Science

    researchmap

  • A short synthesis of (+)-beta-lycorane by asymmetric conjugate addition cascade

    Katsumi Nishimura, Naoshi Fukuyama, Tomohisa Yasuhara, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    TETRAHEDRON   71 ( 39 )   7222 - 7226   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The chiral diether ligand-controlled asymmetric conjugate addition of organolithiums to nona-2,7-dienedioate and subsequent intramolecular conjugate addition of the enolate intermediate gave alltrans trisubstituted cyclohexanes with high ee and yields. Using this methodology, an efficient short asymmetric total synthesis of (+)-beta-lycorane was accomplished in 33% overall yield through five steps from the dienedioate. (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tet.2015.03.014

    Web of Science

    researchmap

  • Cyclic Model for the Asymmetric Conjugate Addition of Organolithiums with Enoates Invited Reviewed

    Katsumi Nishimura, Naoshi Fukuyama, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    SYNTHESIS-STUTTGART   47 ( 15 )   2256 - 2264   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:GEORG THIEME VERLAG KG  

    The chiral diether ligand controlled asymmetric conjugate addition of organolithiums to nona-2,7-dienedioates preferentially proceeds via the s-cis conformation with coordination of the carbonyl oxygen atom to the lithium to give a lithium E-enolate intermediate. Subsequent intramolecular conjugate addition of the enolate also proceeds via a cyclic transition state involving the lithium and the s-cis-enoate, resulting in trans,trans-trisubstituted cyclohexanes with high enantiomeric excesses and yields.

    DOI: 10.1055/s-0034-1380702

    Web of Science

    researchmap

  • Cyclic Model for the Asymmetric Conjugate Addition of Organolithiums with Enoates Reviewed

    Katsumi Nishimura, Naoshi Fukuyama, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    Synthesis   2015, 47, 2256-2264.   2015.5

  • Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M-4 muscarinic acetylcholine receptor agonists

    Atsushi Suwa, Yasuko Konishi, Yoshiharu Uruno, Kentaro Takai, Tomokazu Nakako, Mutsuko Sakai, Takeshi Enomoto, Yoshiaki Ochi, Harumi Matsuda, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 13 )   2909 - 2912   2014.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized novel N-sulfony1-7-azaindoline derivatives as selective M-4 muscarinic acetylcholine receptor agonists. Modification of the N-carbethoxy piperidine moiety of compound 2, an M-4 muscarinic acetylcholine receptor (mAChR)-preferring agonist, led to compound I, a selective M-4 mAChR agonist. Compound 1 showed a highly selective M-4 mAChR agonistic activity with weak hERG inhibition in vitro. A pharmacokinetic study of compound 1 in vivo revealed good bioavailability and brain penetration in rats. Compound 1 reversed methamphetamine-induced locomotor hyperactivity in rats (1-10 mg/kg, po). (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.083

    Web of Science

    researchmap

  • Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M-1 and M-4 muscarinic acetylcholine receptors selective agonists

    Kentaro Takai, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Yoshiharu Uruno, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Hiroyuki Nishikawa, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 14 )   3189 - 3193   2014.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized novel N-substituted 7-azaindoline derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors (mAChRs) agonists. Hybridization of compound 2 with the HTS hit compound 5 followed by optimization of the N-substituents of 7-azaindoline led to identification of compound 1, which showed highly selective M-1 and M-4 mAChRs agonistic activity, weak human ether-a-go-go related gene inhibition, and good bioavailability in multiple animal species. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.085

    Web of Science

    researchmap

  • Syntheses of [C-14]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy] pyridine, a phosphodiesterase 4 inhibitor and its metabolites

    Takeshi Ochi, Yusuke Sawayama, Motoji Kawasaki, Tomohiro Nigo, Masashi Nakao, Tomoki Omodani, Takaaki Sumiyoshi

    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS   57 ( 7 )   477 - 479   2014.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    We describe here the synthesis of [C-14]-2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy] pyridine (1), a phosphodiesterase 4 inhibitor. [C-14]-Labeled 1 was prepared in three steps from [C-14]-2-bromopyridin-3-ol in an overall yield of 32%. Preparation of [C-14]-labeled 2 and 3, two metabolites of 1, is also described.

    DOI: 10.1002/jlcr.3211

    Web of Science

    researchmap

  • Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors

    Motoji Kawasaki, Akira Fusano, Tomohiro Nigo, Shunya Nakamura, Mari N. Ito, Yasuhiro Teranishi, Satoshi Matsumoto, Hiroshi Toda, Naruaki Nomura, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 12 )   2689 - 2692   2014.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 2,3-disubstituted pyridines were synthesized as potential non-emetic PDE4 inhibitors. To decrease brain exposure and minimize emesis, we modified the lipophilic moiety of a series of emetic PDE4 inhibitors and found that introduction of a hydroxy group into the pyridine moiety of the side chain led to non-emetic compounds with preserved PDE4 inhibitory activity. Following optimization at the phenoxy group, we identified compound 1 as a potent non-emetic PDE4 inhibitor. Compound 1 showed significant efficacy in an animal model of asthma without inducing emesis. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.052

    Web of Science

    researchmap

  • Muscarinic acetylcholine receptor activators Reviewed

    Takaaki Sumiyoshi, Takaaki Sumiyoshi, Takeshi Enomoto, Takeshi Enomoto

    Topics in Medicinal Chemistry   13   183 - 212   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Verlag  

    Modulation of muscarinic acetylcholine receptors (mAChRs) is one of the most attractive therapeutic strategies for the treatment of schizophrenia. Pilot clinical studies of the M1/M4 mAChR-preferring agonist xanomeline as well as animal studies using M1–M5 mAChR knockout mice suggest that selective activation of M1 and/or M4 mAChRs is a key concept in the treatment of psychosis and cognitive deficits in patients with schizophrenia. However, over the past two decades, clinical development of mAChR agonists has not been successful mainly due to these agents’ narrow safety margin caused by the lack of true subtype selectivity. However, recent advances in medicinal chemistry might enable researchers to overcome the hurdles that earlier mAChR agonists failed to pass. Here, we describe recent advances in the development of subtype-selective mAChR activators for treatment of schizophrenia.

    DOI: 10.1007/7355_2014_47

    Scopus

    researchmap

  • Experimental and computational study of intermolecular migration of N,N-dimethylcarbamoyl group from N(7) to N(1) on a 7-azaindoline derivative

    Yoshiharu Uruno, Akio Tanaka, Kazuki Hashimoto, Shinya Usui, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Wataru Katoda, Norio Fujiwara, Takaaki Sumiyoshi

    Tetrahedron   69 ( 46 )   9675 - 9681   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier Ltd  

    N,N-Dimethylcarbamoylation of the anilinic nitrogen atom N(1) on the spiro 7-azaindoline consists of two steps. The first step is N,N- dimethylcarbamoylation of the pyridyl nitrogen atom N(7), leading to the formation of an isolable intermediate. The second step is intermolecular migration of the N,N-dimethylcarbamoyl group from the pyridyl nitrogen atom N(7) to the anilinic nitrogen atom N(1). We accomplished optimization of the reaction conditions based on the revealed reaction mechanism and a large scale synthesis of compound 3 in quantitative yield. © 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tet.2013.09.024

    Scopus

    researchmap

  • Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors

    Yoshihiro Kato, Motoji Kawasaki, Tomohiro Nigo, Shunya Nakamura, Akira Fusano, Yasuhiro Teranishi, Mari N. Ito, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY   21 ( 18 )   5851 - 5854   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 2,3-disubstituted pyridines were synthesized and evaluated for their PDE4 inhibitory activity. We successfully modified undesirable cyano group of initial lead compound 2 to 4-pyridyl group with improvement of in vitro efficacy and optimized the position of nitrogen atoms in pyridine moiety and alkylene linker. The most potent compound showed significant efficacy in animal models of asthma and inflammation. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2013.07.007

    Web of Science

    researchmap

  • Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M-1 and M-4 muscarinic acetylcholine receptors agonists

    Kentaro Takai, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Yoshiharu Uruno, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Hiroyuki Nishikawa, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   23 ( 16 )   4644 - 4647   2013.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized N-substituted 8-azatetrahydroquinolone derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors agonists. Optimization of selected derivatives led to the discovery of compound 7 as a highly potent M-1 and M-4 agonist with weak hERG inhibition. Oral administration of compound 7 improved psychosis-like behavior in rats. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2013.06.013

    Web of Science

    researchmap

  • Discovery of novel N-substituted oxindoles as selective M1 and M4 muscarinic acetylcholine receptors partial agonists

    Takaaki Sumiyoshi, Takeshi Enomoto, Kentaro Takai, Yoko Takahashi, Yasuko Konishi, Yoshiharu Uruno, Kengo Tojo, Atsushi Suwa, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi

    ACS Medicinal Chemistry Letters   4 ( 2 )   244 - 248   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Activation of the M1 and M4 muscarinic acetylcholine receptors is thought to play an important role in improving the symptoms of schizophrenia. However, discovery of selective agonists for these receptors has been a challenge, considering the high sequence homology and conservation of the orthosteric acetylcholine binding site among muscarinic acetylcholine receptor subtypes. We report in this study the discovery of novel N-substituted oxindoles as potent muscarinic acetylcholine receptor partial agonists selective for M1 and M4 over M2, M3, and M 5. Among these oxindoles, compound 1 showed high selectivity for the M1 and M4 receptors with remarkable penetration into the central nervous system. Compound 1 reversed methamphetamine- and apomorphine-induced psychosis-like behaviors with low potency to extrapyramidical and peripheral side effects. © 2013 American Chemical Society.

    DOI: 10.1021/ml300372f

    Scopus

    researchmap

  • Asymmetric Synthesis of the Carbon-14-Labeled Selective Glucocorticoid Receptor Modulator using Cinchona Alkaloid Catalyzed Addition of 6-Bromoindole to Ethyl Trifluoropyruvate

    Takaaki Sumiyoshi, Daisuke Urabe, Kengo Tojo, Masato Sakamoto, Kazumi Niidome, Norie Tsuboya, Tomoko Nakajima, Masanori Tobe

    MOLECULES   17 ( 6 )   6507 - 6518   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    We describe in this study the asymmetric synthesis of radioisotope (RI)-labeled selective glucocorticoid receptor modulator. This synthesis is based on optimization of the cinchona alkaloid catalyzed addition of 6-bromoindole to ethyl trifluoropyruvate and Negishi coupling of zinc cyanide to the 6-bromoindole moiety. [C-14] Labeled (-)-{4-[(1-{2-[6-cyano-1-(cyclohexylmethyl)-1H-indol-3-yl]-3,3,3-trifluoro-2-hydroxypropyl} piperidin-4-yl)oxy]-3-methoxyphenyl}acetic acid (-)-1 was synthesized successfully with high enantioselectivity (&gt; 99% ee) and sufficient radiochemical purity.

    DOI: 10.3390/molecules17066507

    Web of Science

    researchmap

  • Asymmetric synthesis of the 6-cyanoindole derivatives as non-steroidal glucocorticoid receptor modulators using (+)- and (-)-tert-butyl 6-cyano-3[3-ethoxy-1,1,1-trifluoro-2-hydroxy-3-oxopropan-2-yl]-1H-indole-1-carboxylate

    Takaaki Sumiyoshi, Kengo Tojo, Daisuke Urabe, Masanori Tobe

    TETRAHEDRON-ASYMMETRY   22 ( 2 )   153 - 160   2011.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We have successfully synthesized enantiomerically pure (+)- and (-)-tert-butyl 6-cyano-3-[3-ethoxy-1,1,1-trifluoro-2-hydroxy-3-oxopropan-2-yl]-1H-indole-1-carboxylate (+)-1 and (-)-1, which are key intermediates of non-steroidal glucocorticoid receptor modulators, by employing a cinchona alkaloid catalyzed addition of 6-cyanoindole to ethyl trifluoropyruvate. The optimized method can be applied to large-scale synthesis. Furthermore, using the key intermediates (+)-1 and (-)-1, enantiomerically pure glucocorticoid receptor modulators (+)-3 and (-)-3 can be synthesized (>99% ee for both compounds). The glucocorticoid receptor binding affinity was influenced by the stereogenic center at the trifluoromethyl alcohol moiety; compound (-)-3 showed a higher binding affinity compared to (+)-3. (C) 2011 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetasy.2011.01.020

    Web of Science

    researchmap

  • Total Synthesis of (-)-Lycorine and (-)-2-epi-Lycorine by Asymmetric Conjugate Addition Cascade

    Ken-ichi Yamada, Mitsuaki Yamashita, Takaaki Sumiyoshi, Katsumi Nishimura, Kiyoshi Tomioka

    ORGANIC LETTERS   11 ( 7 )   1631 - 1633   2009.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ol9003564

    Web of Science

    researchmap

  • 36 Asymmetric Total Syntheses of Lycorine Related Compounds via Tandem Asymmetric Conjugate Addition-Cyclization Reaction of Organolithium Reagent

    Yamada Ken-ichi, Yamashita Mitsuaki, Nishimura Katsumi, Fukuyama Naoshi, Sumiyoshi Takaaki, Tomioka Kiyoshi

    Symposium on the Chemistry of Natural Products, symposium papers   ( 49 )   211 - 216   2007.8

     More details

    Language:Japanese   Publisher:Symposium on the chemistry of natural products  

    We have been involved in development of asymmetric reactions using diether 2 as a chiral chelating ligand and have succeeded in asymmetric addition of organolithium reagents to α,β-unsaturated carboxylates (Scheme 1). The addition of organolithium reagent to α,β-unsaturated carboxylate gives lithium enolate intermediate, whose intermolecular trapping with another α,β-unsaturated carboxylate moiety would produce highly functionalized chiral cyclohexane building blocks, such as 4 (Scheme 2). We planned asymmetric synthesis of Amaryllidaceae alkaloids, lycorine (1) and related compounds using 4 as a key intermediate. The investigation of the key tandem asymmetric conjugate addition-cyclization reaction using chiral ligand 2 revealed that the bulky ortho-substituent, TMS group of aryllithium 6b using important to achieve the first addition step in high enantioselectivity (Scheme 3). Besides, the ethylenedioxy group of α,β-unsaturated carboxylate 3 improves diastereoselectivity in the cyclization step probably because the replacement of H with O makes 1,3-diaxial interaction more unfavorable in the transition state that gives trans-cis isomers 8 (Figure 2). With enantiomerically enriched cyclohexane 9 in hand, we started the asymmetric synthesis of lycorines (Scheme 4). Treatment of 9 with ethanolic HCl gave carboxylic acid 10, whose Curtius rearrangement gave carbamate 11 in good yield. Formation of the tetracyclic core was achieved via lactam formation and Bishler-Napieralski reaction to give ketone 14. Formal synthesis of 1-deoxylycorine was accomplished via double bond formation by IBX oxidation of silyl enolate and reduction of the resulting enone 15. Introduction of 2-hydroxy functionality to ketone 14 was achieved stereoselectively by Magnus' chemistry (Scheme5). Formation of double bond followed by reduction gave 2-epi-lycorine diacetate (23) after acetylation of the resulting 2-epi-lycorine (22).

    DOI: 10.24496/tennenyuki.49.0_211

    CiNii Books

    researchmap

  • Molecular assembly of C-2-symmetric bis-(2S)-2-methyldodecanoylamides of alpha,omega-alkylidenediamines into coiled coil and twisted ribbon aggregates

    T Sumiyoshi, K Nishimura, M Nakano, T Handa, Y Miwa, K Tomioka

    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY   125 ( 40 )   12137 - 12142   2003.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A series of 10 didodecanoylamides of alpha,omega-alkylidenediamines bridged by a straight carbon chain varying in length from 0 to 9 carbons was examined as possible gelator molecules of organic liquids to gain information on the relationships between the spacial arrangement of two amide groups in a molecule and their effects on the microscopic structures of the gel. The structural characteristics of these amides are parallel and antiparallel arrangements of two amide carbonyl groups, which depend on the even and odd numbers of a bridging zigzag carbon chain. The linear alkyl chain moieties and a center carbon chain of diamides intermolecularly interact with each other within the van der Waals contact. Two amide moieties of an even number carbon chain diamide intermolecularly interact with each other by using two pairs of hydrogen bonds with two other molecules in a plane, which formed ribbonlike self-complementarily assembled aggregates. On the other hand, a diamide of an odd number carbon chain forms four independent hydrogen bonds with four other molecules not in a plane, which assembled into woven aggregates. Asymmetric introduction of a methyl group at the alpha-position of the amide groups successfully twists the two side chain van der Waals cores of the chiral diamides in the fixed direction, giving helically twisted ribbon and coiled coil aggregates. The helically twisted ribbon and coiled coil aggregates of these chiral diamides were directly observed by CD, SEM, and TEM, providing a basis for the design of a sophisticated small molecular gelator of a tailor-made shape.

    DOI: 10.1021/ja035085t

    Web of Science

    researchmap

  • Molecular assembly and gelating behavior of didodecanoylamides of alpha,omega-alkylidenediamines

    K Tomioka, T Sumiyoshi, S Narui, Y Nagaoka, A Iida, Y Miwa, T Taga, M Nakano, T Handa

    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY   123 ( 47 )   11817 - 11818   2001.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja0169318

    Web of Science

    researchmap

  • Molecular Assembly and Gelating Behavior of Didodecanoylamides of ┣T00210┫,┣T00360┫-Alkylidenediamides.

    Kiyoshi Tomioka, Takaaki Sumiyoshi, Shinobu Narui, Yasuo Ngaoka, Akira Iida, Yoshihisa Miwa, Tooru Taga, Minoru Nkano, Tetsuro H;a

    J.Am.Che.Soc.   123/47,11817-11818   2001

     More details

    Grant-in-Aid for Scientific Research 200004-200303

    researchmap

▼display all

Books

  • Current Topics-Recent Progress in Medicinal Chemistry-Foreword

    SUMIYOSHI,Takaaki( Role: Sole author)

    Chemical & Pharmaceutical Bulletin  2018.1 

  • 多様な大環状化合物の効率的合成法の開発

    住吉 孝明( Role: Sole author)

    理工学と技術  2014.11 

     More details

  • Muscarinic Acetylcholine Receptor Activators Reviewed

    Takaaki Sumiyoshi, Takeshi Enomoto

    Springer Berlin Heidelberg  2014.4 

     More details

MISC

  • Drug discovery and large-scale synthesis for 7-azaindoline derivatives as potent, orally available, selective M1 and M4 muscarinic acetylcholine receptors agonists

    Yoshiharu Uruno, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Kazuki Hashimoto, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   249   2015.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • Sirtuin 1選択的阻害活性をもつ新規2-hydroxy-1-naphthaldehyde誘導体とその抗がん活性

    瓦谷泰之, 平田佳之, 深田尚文, 住吉孝明, 長岡康夫, 伊藤昭博, 吉田稔, 上里新一

    メディシナルケミストリーシンポジウム講演要旨集   32nd   2014

  • Drug discovery of novel N-substituted oxindoles as potent and high selective muscarinic M-1 and M-4 receptor partial agonist

    Kentaro Takai, Takaaki Sumiyoshi, Yoshiharu Uruno, Kengo Tojo, Atsushi Suwa, Yoko Takahashi, Yasuko Konishi, Takeshi Enomoto, Harumi Matsuda, Mutsuko Sakai, Tomokazu Nakako, Akihiko Kiyoshi, Yasuaki Uematsu, Atsushi Kitamura

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   245   2013.4

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • Asymmetric synthesis of 6-cyanoindoles as nonsteroidal glucocorticoid receptor modulators

    Takaaki Sumiyoshi, Naoki Chiyo, Kengo Tojo, Daisuke Urabe, Masanori Tobe

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   241   2011.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER CHEMICAL SOC  

    Web of Science

    researchmap

Research Projects

  • Drug discovery of CNS-penetrant histonedeacetylase inhibitors

    Grant number:19K07008  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Sumiyoshi Takaaki

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    Central nervous system (CNS) penetrant histone deacetylase (HDAC) inhibitors are the next-generation therapeutic agents based on a novel mechanism of action for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease and psychiatric diseases such as depression. However, many HDAC inhibitors showed have low CNS penetration ability,and therefore we have no HDAC inhibitors approved for the treatment of neuropsychiatric disorders. To overcome the low CNS penetration of known HDAC inhibitors, we focused on the hybrid strategy of histamine H1 receptor antagonist and HDAC inhibitors. We designed, synthesized, and evaluated novel hybrid compounds including the moiety of histamine H1R receptor antagonists which showed high CNS penetration. As a result, we found highly potent,isozyme-selective and CNS-penetrant HDAC inhibitors.In particular, identified HDAC6 inhibitor KH-259 showed significant antidepressant activity in tail-suspension test in mice.

    researchmap

  • Discovery of muscarinic acetylcholine receptor partial agonists

    Grant number:15K18903  2015.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Young Scientists (B)

    Sumiyoshi Takaaki, NAKAMURA Arisa, NAMBARA Takuya, MURAKAMI Masato

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    Muscarinic acetylcholine receptors (M1-M5) are potent drug targets for the treatment of various central nerve system diseases. Among the subtypes, activation of M1 receptor leads to improvement of cognitive impairment. Although many medicinal chemists have challenged to discover selective M1 agonists, most of the compounds did not show enough high subtype-selectivity to dissociate the side effects.
    In this study, we synthesized benzimidazolone derivatives and identified subtype selective M1 receptor partial agonists based on the structure-activity relationship information. The identified compounds are potent for the treatment central nerve system diseases.

    researchmap